Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel, covering 2023-08-08 to 2023-08-08. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC [Phase 3]